In order to elucidate the function of complement component C6, truncated C6 molecules were expressed recombinantly. These were either deleted of the factor I modules (FIMs) (C6des-748 -913) or both complement control protein (CCP) modules and FIMs (C6des-611-913). C6des-748 -913 exhibited approximately 60 -70% of the hemolytic activity of full-length C6 when assayed for Alternative Pathway activity, but when measured for the Classical Pathway, C6des-748 -914 was only 4 -6% as effective as C6. The activity difference between C6 and C6des-748 -913 for the two complement pathways can be explained by a greater stability of newly formed metastable C5b* when produced by the Alternative Pathway compared with that made by the Classical Pathway. The half-lives of metastable C5b* and the decay of 125 I-C5b measured from cells used to activate the Alternative Pathway were found to be about 5-12-fold longer than those same parameters derived from cells that had activated the Classical Pathway.125 I-C5 binds reversibly to C6 in an ionic strength-dependent fashion, but 125 I-C5 binds only weakly to C6des-FIMs and not at all to C6des-CCP/FIMs. Therefore, although the FIMs are not required absolutely for C6 activity, these modules promote interaction of C6 with C5 enabling a more efficient bimolecular coupling ultimately leading to the formation of the C5b-6 complex.Human complement component C6 is a plasma protein of M r ϭ 104,000, which consists of 913 amino acids and two asparaginyl-linked oligosaccharide side chains (1, 2). The protein is a composite containing several discrete modules homologous to those found in thrombospondin, the low density lipoprotein receptor, the epidermal growth factor, factor H, and factor I. The protein also has regional homology with complement C9 and a more restricted homology with the T-lymphocyte granular protein, perforin (1, 2).The function of C6 is to link with C5b in order to form the C5b-6 complex (3, 4). This coupling entails an interaction of C6 with a metastable intermediate of the activated fifth component of complement, designated here as C5b*. After C5 is cleaved by C5 convertase the larger fragment, C5b*, is endowed with a transient ability to form an irreversible complex with C6. If C5b* fails to bind C6 within a short period, C5b* activity decays permanently (4, 5). A further manifestation of this irreversibility is that if C5b-6 were dissociated by chaotrophs, the complex cannot reform (4).The formation of C5b-6 is the first step in the construction of the membrane attack complex (MAC), 1 which is responsible for generating transmembrane channels through target cells. The MAC has the structure of a phospholipid membrane-embedded tubule having a leaflet projecting from within the interior wall. The MAC in its complete state creates a stable circular transmembrane channel of ϳ100 Å (for reviews on the MAC see Refs. 6 -8).How the modules and regions of C6 participate in the formation of the MAC is an ongoing topic of research. The demonstration that C6 can link with C7, C84, and C...